Physician profile
Ryan Ladd
NPI 1508494592
$807.65
in general payments reported to CMS, 2019-2025
10 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $145 · 2023: $327 · 2024: $71.76 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $473.11 | 2022-2025 | Nemluvio |
| Argenx US, INC. | $108.02 | 2023 | Vyvgart |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $74.43 | 2023 | Altreno, Jublia, Arazlo |
| Janssen Biotech, INC. | $30.77 | 2025 | Tremfya |
| Arcutis Biotherapeutics, INC. | $27.62 | 2025 | Zoryve |
| Regeneron Healthcare Solutions, INC. | $22.34 | 2025 | Dupixent |
| Pfizer INC. | $20.87 | 2025 | |
| Lnhc, INC | $20.15 | 2025 | Zelsuvmi |
| Ucb, INC. | $16.39 | 2025 | Bimzelx |
| Leo Pharma INC. | $13.95 | 2025 | Anzupgo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Ladd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.